Analyzing movement in patients with musculoskeletal tumors
Movement Analysis in Musculoskeletal Oncology: a Pilot Study
This study is testing how movement changes in patients with musculoskeletal tumors after they receive treatment to help understand their recovery better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 6 Years and up |
| Sex | All |
| Sponsor | Regina Elena Cancer Institute Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Rome) |
| Trial ID | NCT05918549 on ClinicalTrials.gov |
What this trial studies
This pilot study is a noninterventional, prospective, multicenter investigation focusing on patients with primary and secondary musculoskeletal tumors. It aims to evaluate functional outcomes after therapy by employing both subjective assessments and quantitative motion detection techniques. The study will include patients who are scheduled for surgery or other treatments and will track their progress over at least six months. By analyzing movement patterns, the study seeks to provide insights into recovery and rehabilitation.
Who should consider this trial
Good fit: Ideal candidates include individuals over the age of 6 with a diagnosis of musculoskeletal tumors who are scheduled for surgical or other therapeutic interventions.
Not a fit: Patients who are unable to undergo pre- and post-treatment assessments will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of functional recovery in patients with musculoskeletal tumors, leading to improved rehabilitation strategies.
How similar studies have performed: While this approach is relatively novel, similar studies in motion analysis have shown promise in other areas of oncology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 6 years * Diagnosis of primary and secondary tumors of the musculoskeletal system * Patients who will need to undergo surgery for bone resection or wide excision of soft tissue lesion, and/or radiation or drug treatments * Availability of follow-up data (for at least 6 months) * Written informed consent Exclusion Criteria: - Inability to perform pre-post treatment assessment
Where this trial is running
Rome
- "Regina Elena" National Cancer Institute — Rome, Italy (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.